Cost per Test Equipment, Becton BD BACTEC FX and Bruker MALDI Biotyper for the Infectious Disease Laboratory at Walter Reed National Military Medical Center
Cancelled Pre-Solicitation Posted
- Solicitation number
- HT0014-03042025
- Agency
-
Defense Health Agency
Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Place of performance
- Bethesda, Maryland 20889, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Health Agency is seeking to procure diagnostic reagents and systems from BD Diagnostics for the Infectious Disease Laboratory at Walter Reed National Military Medical Center. The pre-solicitation notice focuses on acquiring specific medical testing equipment including BD BACTEC FX, Phoenix M50, Bruker MALDI, and BD Affirm platforms, with an emphasis on proprietary reagents required for accurate patient care support. The procurement is critical to maintaining continuity of laboratory operations, as alternative vendors would necessitate extensive instrument validation and potentially disrupt patient testing capabilities. This sources sought notice indicates the agency's intent to ensure uninterrupted access to specialized diagnostic technologies through the original equipment manufacturer. The current opportunity is posted on March 4, 2025, with responses due by March 10, 2025, targeting the Analytical Laboratory Instrument Manufacturing sector.
The contract opportunity does not have a specific set-aside designation and appears to be an open procurement. The current platforms are leased from BD Diagnostics, suggesting a potential sole-source or limited competition procurement approach. While specific award values are not disclosed, the solicitation emphasizes the substantial operational risks and increased costs associated with changing vendors or instrumentation. The contract will support the Infectious Disease Laboratory's ongoing diagnostic testing capabilities, with a focus on maintaining existing platform compatibility and ensuring rapid, accurate medical testing processes. The procurement falls under NAICS Category 334516 for Analytical Laboratory Instrument Manufacturing and PSC Category 6545 for Replenishable Field Medical Sets, Kits, and Outfits, indicating a specialized medical equipment and supply procurement.
Notice text
This is a Sources Sought notice. This action is being taken to procure BD Diagnostics systems to use reagents to provide patient care support in the Infectious Disease Laboratory. The reagents are proprietary to the manufacturing vendor, BD and are required for use with current installed platforms which are the BACTEC FX, Phoenix M50, Bruker MALDI, and BD Affirm platforms. Procurement of these reagents through the manufacturing vendor, BD, ensures that the Infectious Disease Laboratory can accurately receive and amend shipments of reagents in a time critical manner as well as order supplies required to ensure continuity of operations. The Infectious Disease Laboratory currently has platforms that are leased from BD and require BD reagents and support. Failure to procure these specific services and products will degrade the patient care capacity of the Infectious Disease Laboratory. If testing supplies could not be purchased through BD Diagnostics, supplies would have to be purchased through another source, which would violate the terms of the agreement and necessitate removal and replacement of all instrumentation. This would significantly increase operating costs and delay patient testing as new instrumentation requires extensive validations before testing of patient samples can be performed.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity